Sensory Characteristics and Psychosocial Factors Related With Non-specific Neck Musculoskeletal Pain Chronification (CNSNP)
22 de janeiro de 2021 atualizado por: Pablo Herrero Gallego, Universidad San Jorge
Chronic pain is commonly defined as any pain which lasts more than 12 weeks.
Chronic non-specific neck pain (CNSNP) has no specific underlying disease causing the pain.
There are neurophysiological factors that may modulate pain response and perception in the central nervous system, producing sensory changes such as the presence of temporal summation (TS) and pressure, cold or heat hyperalgesia.
TS describes the progressive increase in reported pain intensity as a function of repeated noxious stimulation (e.g.
thermal, electrical or mechanical).
TS and hyperalgesia are measured through quantitative sensory tests (QST) where pain pressure thresholds (PPT) are measured with an algometer.
The current evidence show that PPTs are significantly lower compared to healthy subjects and the association between PPTs, pain intensity and disability are inconsistent.
Further, there are psychosocial factors (catastrophizing, kinesiophobia, stress…) that may influence the pain experience.
This psychosocial factors associated with chronic pain are not systematically collected in the QST literature complicating the interpretation of data.
The objectives of this study are 1) to determine disability, sensory (TS and PPTs) and psychosocial changes (kinesiophobia, catastrophizing, sleep quality, life quality, stress and anxiety) in the natural evolution or in the result of physiotherapy treatment in CNSNP individuals, 2) to study the correlations between disability, psychosocial and sensory factors and 3) to observe if there is a homogeneity between the subjects.
Visão geral do estudo
Status
Concluído
Condições
Intervenção / Tratamento
Tipo de estudo
Observacional
Inscrição (Real)
68
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
-
Zaragoza, Espanha, 50009
- Hospital General de la Defensa
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
18 anos a 65 anos (Adulto, Adulto mais velho)
Aceita Voluntários Saudáveis
Sim
Gêneros Elegíveis para o Estudo
Tudo
Método de amostragem
Amostra Não Probabilística
População do estudo
The study was divided into 2 groups: individuals with Chronic Non-Specific Neck Pain and healthy controls.
Descrição
Inclusion criteria for individuals with CNSNP were:
- age between 18 and 65 years;
- capable to understand, write, and speak in Spanish;
- having suffered neck pain during the last 12 weeks at least;
- pain localized in the neck region with or without pain radiation;
- Negative Spurling test;
- Negative Self-Administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS);
- Negative Upper Limb Tension Test for the median nerve;
- PainDetect test with non-neuropathic pain result. .
Exclusion Criteria:
- Presence of red flag as reported in the medical history (i.e. tumor, fracture, metabolic diseases, rheumatoid arthritis, osteoporosis);
- Neck pain with cervical radiculopathy;
- fibromyalgia syndrome,
- previous neck surgery;
- currently undergoing any type of pain treatment or having received physical therapy in the previous 3 months.
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
Chronic Non-Specific Neck Pain
Patients with chronic non-specific neck pain.
No interventions
|
Observational study
|
|
Control/Healthy Group
Volunteers without pain.
No interventions.
|
Observational study
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Neck Disability Index Change
Prazo: T0 (baseline); T1 (1 month); T2 (6 months).
|
It is a 10-item questionnaire that measures a patient's self-reported neck pain related disability.
Questions include activities of daily living, such as: personal care, lifting, reading, work, driving, sleeping, recreational activities, pain intensity, concentration and headache.
The 10 item scores are then summed to yield a global NDI score, which has a range of 0-50 where higher values reflect greater neck disability. 1 and 6-month results were subtracted from baseline.
As such, positive change scores for neck disability indicate improvement
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Quick-DASH change
Prazo: T0 (baseline); T1 (1 month); T2 (6 months).
|
The purpose of the QuickDASH is to use 11 items to measure physical function and symptoms in people with any or multiple musculoskeletal disorders of the upper limb.
The QuickDASH is a widely used reference of self reported disability.
The 11 item scores are then summed to yield a global QuickDASH score, which has a range of 11-100 where higher values reflect greater shoulder/arm disability. 1 and 6-month results were subtracted from baseline.
As such, positive change scores for shoulder/arm disability indicate improvement
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Pressure Pain Threshold change
Prazo: T0 (baseline); T1 (1 month); T2 (6 months).
|
Pressure pain threshold (PPT) is defined as the minimum force applied which induces pain.
This measure has proven to be commonly useful in evaluating tenderness symptom.
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Temporal Summation change
Prazo: T0 (baseline); T1 (1 month); T2 (6 months).
|
Temporal summation is a clinical measure of central sensitization in which a high frequency of action potentials in the presynaptic neuron elicits postsynaptic potentials that overlap and summate with each other.
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Area of pain assessed by bodycharts change
Prazo: T0 (baseline); T1 (1 month); T2 (6 months).
|
Participants have to draw on a tablet-based digital body chart (NavigatePain©, Aalborg University, Aalborg, Denmark) the body region in which they felt pain more frequently during the previous month.
The use of pain drawings has been found to be reliable in chronic low back, neck, shoulder, and arm pain.
Digital pain drawings have also been shown reliable, valid and comparable to paper drawings and useful in clinical population.
The size of the pain area was extracted and expressed in pixels.
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Pain Intensity change- Visual Analogic Scale
Prazo: T0 (baseline); T1 (1 month); T2 (6 months).
|
Self-perceived neck pain will record using a Visual Analogue Scale (VAS).
Participants have to mark on a 10-cm line their average current neck pain between 0 ("no pain") and 10 ("worst possible pain").
The VAS is a reliable and valid measurement of pain
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Pain Duration change
Prazo: T0 (baseline); T1 (1 month); T2 (6 months).
|
Duration of pain in months
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Catastrophism change. Pain Catastrophizing Scale
Prazo: T0 (baseline); T1 (1 month); T2 (6 months).
|
People are asked to indicate the degree to which they have the above thoughts and feelings when they are experiencing pain using the 0 (not at all) to 4 (all the time) scale.
A total score is yielded (ranging from 0-52), along with three subscale scores assessing rumination, magnification and helplessness.
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Kinesiophobia change. Tampa Scale for Kinesiophobia
Prazo: T0 (baseline); T1 (1 month); T2 (6 months).
|
Tampa Scale for Kinesiophobia (TSK) The TSK is a 17-item self-report measure of fear of movement and (re)injury.
Four of the items are negatively worded and reversed scored (4, 8, 12, and 16).
Ratings are summed to yield a total score where higher values reflect greater fear of (re)injury.
The 17 item scores are then summed to yield a global TSK score, which has a range of 11-44.
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Quality of Life change. The 5-level EQ-5D version (EQ-5D-5L)
Prazo: T0 (baseline); T1 (1 month); T2 (6 months).
|
The EQ-5D is a frequently used generic quality of life questionnaire, designed by the EuroQoL.
The EQ-5D-5L is an instrument widely used to measure and evaluate general health status.
The EQ-5D-5L descriptive system describes general health in terms of five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression.
Each dimension has five levels, indicating no problems, slight problems, moderate problems, severe problems, and extreme problems resulting in a total of 3,125 unique health states.
Besides, the EQ-5D-5L also includes a visual analogue scale (EQ-VAS), which recorded the patient's self-rated health on a 20 cm vertical, visual analogue scale with endpoints (0; 100) labeled 'the best health you can imagine' and 'the worst health you can imagine'
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Stress change. Perceived Stress Scale
Prazo: T0 (baseline); T1 (1 month); T2 (6 months).
|
he Perceived Stress Scale (PSS) inquire about feelings and thoughts that tap the degree to which respondents find their current life situation unpredictable, uncontrollable and stressful.
Respondents indicate how often in the past month they have felt or thought a certain way on a 5-point Likert scale (0 = never, 1 = almost never, 2 = sometimes, 3 = fairly often, 4 = very often).
The higher the score the higher the perceived stress is.
The 14 item scores are then summed to yield a global PSS score, which has a range of 0-56
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Quality of Sleep change . Pittsburgh Questionnaire
Prazo: T0 (baseline); T1 (1 month); T2 (6 months).
|
PSQI consists of 19 self-rated questions.
The 19 self-rated questions asses a wide variety of factors relating to sleep quality, including estimates of sleep duration and latency and of the frequency and severity of specific sleep-related problems.
Theses 19 items are grouped into seven component scores, each weighted equally on a 0-3 scale.
The seven component scores are then summed to yield a global PSQI score, which has a range of 0-21; higher scores indicate worse sleep quality.
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
|
Anxiety-Depression change. DASS 21.
Prazo: T0 (baseline); T1 (1 month); T2 (6 months).
|
The DASS is a self-report measure, designed to assess the unique and unrelated aspects of anxiety and depression, as well as a third construct (termed stress) that assesses the features common to anxiety and depression.
The DASS-21 is comprised of three scales, Depression, Anxiety, and Stress, each of which consists of 7 items.
The 21 item scores are then summed to yield a global DASS-21 score, which has a range of 0-63
|
T0 (baseline); T1 (1 month); T2 (6 months).
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Colaboradores
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
15 de abril de 2020
Conclusão Primária (Real)
15 de dezembro de 2020
Conclusão do estudo (Real)
22 de janeiro de 2021
Datas de inscrição no estudo
Enviado pela primeira vez
25 de março de 2020
Enviado pela primeira vez que atendeu aos critérios de CQ
30 de março de 2020
Primeira postagem (Real)
1 de abril de 2020
Atualizações de registro de estudo
Última Atualização Postada (Real)
25 de janeiro de 2021
Última atualização enviada que atendeu aos critérios de controle de qualidade
22 de janeiro de 2021
Última verificação
1 de janeiro de 2021
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- CNSNP-USJ
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
NÃO
Descrição do plano IPD
Data will be provided based on request to authors by email to gortego@usj.es
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .